Shilpa Gupta/X
Dec 9, 2024, 02:49
Shilpa Gupta: Amazing overview of neoadjuvant treatment landscape in MIBC by Mamta Parikh
Shilpa Gupta, Director of Genitourinary Oncology at Cleveland Clinic, shared a post on X:
“Amazing overview of neoadjuvant tx landscape in muscle invasive bladder cancer by Mamta Parikh. Exciting to see such rapid developments with novel agents for our patients! Shoutout to Roger Li for CORE-002 Andrea Necchi for SURE-01, SURE-02 and SunRise4.”
Dr. Shilpa Gupta is the Director of Genitourinary Oncology, a staff member in Hematology and Oncology and a Professor of Medicine at Cleveland Clinic. Dr. Gupta’s extensive research focuses on novel drug development and biomarkers of response/resistance in bladder cancer, contributing to numerous published works and leadership roles in clinical trials.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 9, 2024, 02:44
Dec 9, 2024, 02:32
Dec 9, 2024, 02:22
Dec 8, 2024, 23:37